Literature DB >> 9781917

Endothelium-dependent vascular effects of Pycnogenol.

D F Fitzpatrick1, B Bing, P Rohdewald.   

Abstract

Pycnogenol (P) is purported to exhibit effects that could be beneficial in terms of prevention of chronic age-related diseases such as atherosclerosis. The most studied of these effects is its antioxidant/free radical-scavenging activity. In this study, we investigated the possibility that this supplement might produce vascular effects by stimulation of nitric oxide (NO) production by vascular endothelial cells. In the in vitro experiments, P (1-10 microg/ml) relaxed epinephrine (E)-, norepinephrine (NE)-, and phenylephrine (PE)-contracted intact rat aortic ring preparations in a concentration-dependent manner. However, when the endothelial lining of the aortic ring was removed, P had no effect, indicating an endothelium-dependent relaxing (EDR) effect. This EDR response was caused by enhanced NO levels, because the NO synthase (NOS) inhibitor N-methyl-L-arginine (NMA) reversed (or prevented) the relaxation, and this response, in turn, was reversed by addition of L-arginine, the normal substrate for NOS. Pycnogenol-induced EDR persisted after exposure of intact rings to high levels of superoxide dismutase (SOD), suggesting that the mechanism of EDR did not involve scavenging of superoxide anion. In addition to causing relaxation, preincubation of aortic rings with P (1-10 microg/ml) inhibited subsequent E- and NE-induced contractions in a concentration-dependent manner. Fractionation of P by Sephadex LH-20 chromatography resulted in three fractions, one of which (fraction 3, oligomeric procyanidins) exhibited potent EDR activity. These results indicate that P, in addition to its antioxidant activity, stimulates constitutive endothelial NOS (eNOS) activity to increase NO levels, which could counteract the vasoconstrictor effects of E and NE. Furthermore, additional protective effects could result from the well-established properties of NO to decrease platelet aggregation and adhesion, as well as to inhibit low-density lipoprotein (LDL) cholesterol oxidation, all of which could protect against atherogenesis and thrombus formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781917     DOI: 10.1097/00005344-199810000-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  17 in total

1.  Improvements of venous tone with pycnogenol in chronic venous insufficiency: an ex vivo study on venous segments.

Authors:  Gianni Belcaro; Mark Dugall; Roberta Luzzi; M Hosoi; Marcello Corsi
Journal:  Int J Angiol       Date:  2014-03

2.  An Observational Study to Evaluate the Prevalence of Erectile Dysfunction (ED) and Prescribing Pattern of Drugs in Patients with ED Visiting an Andrology Specialty Clinic, Mumbai: 2012-14.

Authors:  Amit S Mutha; Vijay R Kulkarni; Sagar B Bhagat; Amit S Beldar; Sadiq B Patel
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 3.  Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF.

Authors:  Valérie B Schini-Kerth; Cyril Auger; Jong-Hun Kim; Nelly Etienne-Selloum; Thierry Chataigneau
Journal:  Pflugers Arch       Date:  2010-03-12       Impact factor: 3.657

4.  Treatment of ADHD with French maritime pine bark extract, Pycnogenol.

Authors:  Jana Trebatická; Sona Kopasová; Zuzana Hradecná; Kamil Cinovský; Igor Skodácek; Ján Suba; Jana Muchová; Ingrid Zitnanová; Iweta Waczulíková; Peter Rohdewald; Zdenka Duracková
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-05-13       Impact factor: 4.785

5.  Pycnogenol for diabetic retinopathy. A review.

Authors:  F Schönlau; P Rohdewald
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

6.  Natural anti-inflammatory agents for pain relief.

Authors:  Joseph C Maroon; Jeffrey W Bost; Adara Maroon
Journal:  Surg Neurol Int       Date:  2010-12-13

7.  Preventive effect of pine bark extract (flavangenol) on metabolic disease in Western diet-loaded tsumura suzuki obese diabetes mice.

Authors:  Tsutomu Shimada; Mitsutaka Kosugi; Daisuke Tokuhara; Masahito Tsubata; Tomoyasu Kamiya; Mayu Sameshima; Rika Nagamine; Kinya Takagaki; Ken-Ichi Miyamoto; Masaki Aburada
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-17       Impact factor: 2.629

8.  Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract.

Authors:  S Iravani; B Zolfaghari
Journal:  Res Pharm Sci       Date:  2011-01

Review 9.  Polyphenols and human health: prevention of disease and mechanisms of action.

Authors:  David Vauzour; Ana Rodriguez-Mateos; Giulia Corona; Maria Jose Oruna-Concha; Jeremy P E Spencer
Journal:  Nutrients       Date:  2010-11-08       Impact factor: 5.717

10.  Potential benefits on impairment of endothelial function after a high-fat meal of 4 weeks of flavonoid supplementation.

Authors:  T A Barringer; L Hatcher; H C Sasser
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.